NCT02801123: MATCH

The MATCH Study: Mindfulness And Tai Chi for Cancer Health

Status unknown NA Last updated 23 March 2023

What this trial tests

NA trial testing Mindfulness Based Cancer Recovery (MBCR) in Cancer in 600 participants. Status unknown.

Timeline

29 August 2016

Primary endpoint
31 December 2020

31 December 2023

Quick facts

Lead sponsor	Linda E. Carlson
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	600
Start date	29 August 2016
Primary completion	31 December 2020
Estimated completion	31 December 2023
Sites	2 locations across Canada

Drugs / interventions tested

• Mindfulness Based Cancer Recovery (MBCR)
• Tai Chi/Qigong (TCQ) for Cancer Patients

Conditions studied

• Cancer — all drugs for Cancer →

Sponsor

Linda E. Carlson

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: As more people survive cancer, the importance of research on effective interventions for improving quality of life (QOL) amongst survivors is growing. Two interventions with a substantial evidence-base are Mindfulness-Based Cancer Recovery (MBCR) and Tai chi/Qigong (TCQ). However, these interventions have never been directly compared.

Objectives: (1) To compare MBCR and TCQ to each other and a waitlist control condition using an innovative, randomized, preference-based comparative effectiveness trial (CET) design that takes into account potential moderating factors that might predict differential response. (2) To investigate the impacts of MBCR and TCQ on a range of biological outcomes including immune processes, blood pressure, heart rate variability, stress hormones, cellular aging, and gene expression.

Methods: The study design is a preference-based multi-site randomized CET incorporating two Canadian sites (Calgary, AB and Toronto, ON). Participants (N total = 600). Participants with a preference for either MBCR or TCQ will get their preferred intervention; while those without a preference will be randomized into either of the two interventions. Within the preference and non-preference groups, participants will also be randomized into immediate intervention groups or a wait-list control. Outcome measures to be assessed pre- and post-intervention and at 6-month follow up include psychological outcomes (mood, stress, mindfulness, spirituality, post-traumatic growth), QOL, symptoms (fatigue, sleep), physical function (strength, endurance), and exploratory analyses of biomarkers (cortisol slopes, cytokines, blood pressure/heart rate variability, telomere length, gene expression), and health economic measures.

Hypotheses: The investigators theorize that both MBCR and TCQ will improve outcomes amongst survivors relative to treatment as usual, particularly if patients have a strong preference for a particular intervention. Specifically, the investigators hypothesize that MBCR may be superior to TCQ on measures related to stress and mood. Conversely, TCQ may be superior to MBCR in improvement of physical and functional measures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Factors related to dropout in integrative oncology clinical trials: interim analysis of an ongoing comparative effectiveness trial of mindfulness-based cancer recovery and Tai chi/Qigong for cancer health (The MATCH study).
   Oberoi D, Piedalue KL, Pirbhai H, Guirguis S, et al · · 2020 · cited 5× · PMID 32680556 · DOI 10.1186/s13104-020-05172-5